Valeant Pharmaceuticals International (VRX) 47.95 -0.48

Valeant Pharmaceuticals International, Inc.
(VRX) 47.95 -0.48

Last Trade:	47.92	Day Range:	47.15 - 48.17
Trade Time:	06:05PM	52wk Range:	32.05 - 59.94
Prev. Close:	48.40	Market Cap:	14.28B
Open:	47.73	Div Yield:	0.79
Volume:	1057657	PE:
EPS:	0.00

The Latest On VRX

Valeant Pharmaceuticals To Syndicate Incremental Term Loans 5/30/12 8:02am

Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal for C$28M 5/24/12 7:58am

UPDATE: Morgan Stanley Raises PT to $61 on Valeant Pharmaceuticals on Deals 5/7/12 9:04am

Top 4 Stocks In The Drug Delivery Industry With The Highest Operating Margin 5/7/12 2:10am

Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical for $64M 5/3/12 8:12am

Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Atlantis Pharma in Mexico for $71M 4/18/12 8:06am

Valeant Pharmaceuticals to Acquire Pedinol 4/12/12 8:01am

ISTA to be Acquired by Bausch & Lomb 3/27/12 10:25am

Benzinga's M&A Chatter for Monday March 26, 2012 3/26/12 6:03pm

Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia 3/26/12 9:17am

Valeant Pharmaceuticals Agrees to Acquire Certain Assets From Gerot Lannach 3/13/12 8:00am

Valeant Pharmaceuticals Buys 19.9% Stake In Brazilian Company 3/12/12 8:51am

Valeant Pharmaceuticals To Syndicate Incremental Term Loans 5/30/12

Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal for C$28M 5/24/12

UPDATE: Morgan Stanley Raises PT to $61 on Valeant Pharmaceuticals on Deals 5/7/12

Top 4 Stocks In The Drug Delivery Industry With The Highest Operating Margin 5/7/12

Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical for $64M 5/3/12

Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Atlantis Pharma in Mexico for $71M 4/18/12

Valeant Pharmaceuticals to Acquire Pedinol 4/12/12

ISTA to be Acquired by Bausch & Lomb 3/27/12

Benzinga's M&A Chatter for Monday March 26, 2012 3/26/12

Valeant Pharmaceuticals Agrees to Acquire Natur Produkt in Russia 3/26/12

Valeant Pharmaceuticals Agrees to Acquire Certain Assets From Gerot Lannach 3/13/12

Valeant Pharmaceuticals Buys 19.9% Stake In Brazilian Company 3/12/12

Top 4 Stocks In The Drug Delivery Industry With The Highest Operating Margin 5/7/12

Benzinga's M&A Chatter for Monday March 26, 2012 3/26/12

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Cash 3/7/12

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS 2/21/12

Benzinga's M&A Chatter for Monday February 13, 2012 2/13/12

Benzinga's M&A Chatter for Monday January 30, 2012 1/30/12

Best Specialty Pharma Stocks Picked by UBS 1/20/12

Benzinga's M&A Chatter for Tuesday January 17, 2012 1/17/12

Benzinga's M&A Chatter for Friday December 16, 2011 12/16/11

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS 12/13/11

12 Most Popular Healthcare Stocks Among Hedge Funds 8/25/11

UPDATE: Morgan Stanley Raises PT to $61 on Valeant Pharmaceuticals on Deals 5/7/12

ISTA to be Acquired by Bausch & Lomb 3/27/12

Benzinga's Top Upgrades 1/10/12

Morgan Stanley Upgrades Valeant Pharmaceuticals to Overweight 1/10/12

J.P. Morgan Publishes 3Q/11 Preview on Specialty Pharmaceuticals 10/17/11

Deutsche Bank Reports Earnings on Specialty Pharmaceuticals 10/11/11

Deutsche Bank Maintains Buy on Valeant Pharmaceuticals 8/31/11

DB Changes PT And EPS Estimates Of Valeant 8/5/11

Deutsche Bank Lowers PT on Valeant Pharmaceuticals To $57 8/5/11

UPDATE: Piper Jaffray Lowering Price Target On Valeant Pharmaceuticals 8/5/11

Piper Jaffray Lowers PT On Valeant Pharmaceuticals To $51 8/5/11

Deutsche Bank Reiterates Buy on Valeant Pharmaceuticals, Raises PT to $64 7/18/11

Trade VRX
NOW!

Partner Headlines

Valeant's Acquisition Spree Continues - Analyst Blog 5/29/12

Obagi Puts Its Problems Behind It (OMPI, MRX, VRX, AGN) 5/25/12

4 Stocks Sitting On Support (POT, VRX, STX, WYNN) 5/25/12

Valeant Pharmaceuticals - Aggressive Growth 5/23/12

Insiders Trading VRX, V, SONS, ANGI 5/22/12

Weekly Top Insider Buys: IBM, BAC, SPG, HES, VRX 5/21/12

Insiders Trading VRX, RAX, GHDX 5/17/12

5 Stocks That Insiders Love Right Now 5/16/12

Health Care Sector Wrap 5/15/12

Stocks End Mixed After Seesaw Session; Europe Weighs 5/7/12

Press Releases

Critical Alerts For Corning, Expedia, Agnico Eagle Mines, Brinker International, and Valeant Pharmaceutical Released By InvestorsObserver 5/24/12 Newswire

Gentium Reports First Quarter Financial Results 5/17/12 GlobeNewswire

Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 5/3/12 Newswire

Valeant Pharmaceuticals To Webcast 2012 Annual Meeting Of Shareholders 4/30/12 Newswire

Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference 4/27/12 Newswire

Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012 4/16/12 Newswire

Critical Alerts for Morgan Stanley, LinkedIn, Valeant, Cavium, and Clean Energy Fuels Released by Seven Summits Research 2/28/12 Newswire

Valeant Pharmaceuticals Reports 2011 Fourth Quarter Financial Results 2/27/12 Newswire

Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012 2/8/12 Newswire

Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference 1/6/12 Newswire

Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance 12/22/11 Newswire

Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty 12/16/11 Newswire

Get the latest VRX stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Valeant Pharmaceuticals International, Inc. stock price.

Valeant Pharmaceuticals International, Inc. by YCharts

Valeant Pharmaceuticals International (VRX) 47.95 -0.48

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On VRX

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social